VNDA - Vanda Pharmaceuticals Inc. (VNDA) Q1 2024 Earnings Call Transcript

2024-05-08 21:48:11 ET

Vanda Pharmaceuticals, Inc. (VNDA)

Q1 2024 Earnings Conference Call

May 08, 2024 04:30 pm ET

Company Participants

Mihael Polymeropoulos - President, Chairman and CEO

Kevin Moran - CFO

Tim Williams - Senior Vice President and General Counsel

Conference Call Participants

Presentation

Operator

Thank you for standing by. My name is Hermine, and I will be your conference operator today. At this time, I would like to welcome everyone to Q1 2024 Vanda Pharmaceuticals, Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the call over to Vanda's Chief Financial Officer, Kevin Moran. Please go ahead.

Kevin Moran

Thank you, Hermine. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' first quarter 2024 performance. Our first quarter 2024 results were released this afternoon and are available on the SEC's EDGAR System and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website....

For further details see: